TD Cowen initiated coverage of Kiniksa (KNSA) with a Buy rating and $60 price target The firm says Kiniksa is at a “pivotal stage” as Arcalyst’s launch continues to ramp while KPL-387 could offer more favorable dosing. This could extend the franchise and significantly improve the company’s earnings, the analyst tells investors in a research note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KNSA:
